BSGM (BioSig Technologies) Float Percentage Of Total Shares Outstanding : 84.19% (As of May. 03, 2025)

View and export this data going back to 2014. Start your Free Trial

What is BioSig Technologies Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, BioSig Technologies's float shares is 20.42 Mil. BioSig Technologies's total shares outstanding is 24.25 Mil. BioSig Technologies's float percentage of total shares outstanding is 84.19%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, BioSig Technologies's Insider Ownership is 39.83%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, BioSig Technologies's Institutional Ownership is 35.56%.

BioSig Technologies Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

BioSig Technologies's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding	=	Float Shares	/	Total Shares Outstanding
	=	20.42	/	24.25
	=	84.19%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioSig Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioSig Technologies Inc (NAS:BSGM) » Definitions » Float Percentage Of Total Shares Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

55 Greens Farms Road, 1st Floor, Westport, CT, USA, 06880

Website

https://www.biosig.com

BioSig Technologies Inc is a commercial-stage medical device company with an advanced digital signal processing technology platform to deliver insights to the treatment of cardiovascular arrhythmias. Through collaboration with physicians, experts, and healthcare leaders across the field of electrophysiology (EP), It is committed to addressing healthcare's biggest priorities saving time, saving costs, and saving lives. Its first product, the PURE EP System, is an FDA-cleared non-invasive class II device consisting of a unique combination of hardware and software designed to provide unprecedented signal clarity and precision for real-time visualization of intracardiac signals paving the way for personalized patient care.

Executives

Kenneth L Londoner	director, 10 percent owner	10 RED COAT ROAD, WESTPORT CT 06880
Steven J Buhaly	officer: Chief Financial Officer	1195 NW LOMPTON DRIVE, BEAVESTON OR 97006
John Sieckhaus	officer: Chief Operating Officer	C/O BIOSIG TECHNOLOGIES, 55 GREENS FARMS ROAD, WESTPORT CT 06880
Steve Chaussy	officer: Chief Financial Officer	9780 E AVE, HESPERIA CA 92345
Patrick Joseph Gallagher	director	275 PLEASANT HILL RD., FLANDERS NJ 07836
Gray Fleming	officer: Chief Commercial Officer	C/O BIOSIG TECHNOLOGIES, INC., 55 GREENS FARMS ROAD, WESTPORT CT 06880
James L Klein	director	2300NE BROOKWOOD PKWY, HILLSBORO OR 97124
Frederick Hrkac	director	C/O BIOSIG TECHNOLOGIES, 55 GREENS FARMS ROAD, WESTPORT CT 06880
James J Barry	director	C/O INSPIREMD, INC., 4 MENORAT HAMAOR ST., TEL AVIV L3 6744832
Jeffrey F Odonnell	director	126 ROSSMORE DRIVE, MALVERN PA 19355
Anthony P. Zook	director	C/O VIVUS, INC., 351 EAST EVELYN AVENUE, MOUNTAIN VIEW CA 94041
Jerome B Zeldis	director	8767 E. VIA DE VENTURA, SUITE 190, SCOTTSDALE AZ 85258
Martha Pease	director	33 SEAVIEW, MADISON CT 06443
John M Kowalski	officer: VP of Sales	54 WILTON ROAD, 2ND FLOOR, WESTPORT CT 06880
Samuel E Navarro	director	C/O STRATA SKIN SCIENCES, INC., 5 WALNUT GROVE DRIVE, SUITE 140, HORSHAM PA 19044